Scholars Central

Conference abstractPublished 18 Jul 2018

Non-coding Pri-miRNA-encoded novel peptides/proteins regulate migration of cancer cells

Authors: Jinbo Fang, Sharif Morsalin, Linda Egbosiuba, Veena N Rao, E Shyam P Reddy

Cancer Biology Program, Department of OB/GYN, Morehouse School of Medicine, Georgia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Only two percent of the Human genome was shown to code for proteins and the rest of the 80-90 percent was shown to transcribe into non-coding RNAs such as pri-miRNAs, lncRNAs and CircRNAs. Mature miRNAs are known to be processed from large primary transcript (pri-miRNAs) in two stages. First stage involves processing of pri-miRNA into shorter pre-miRNA followed by second stage, where pre-miRNA will be processed to mature miRNAs. Earlier studies suggested that deregulation or aberrant expression of miRNAs can lead to several human diseases and cancers (including gynaecological cancers). Recently, it was shown that pri-miRNA codes for peptides (miPEPs) that regulate the expression of active mature miRNAs in plant cells. Since miRNAs are well conserved in humans, animals and plants, it is important to study whether primiRNAs code for such peptides/proteins in mammalian cells. In addition, it will be highly significant and remarkable, if one can prove the presence/absence of pri-miRNA encoded peptides in normal and cancer cells and their metastatic cells and show that they function as tumor suppressors and/or oncogenes like in the case of miRNAs. Here, we demonstrate for the first time, the presence of an ORF in pri-miRNA which codes for - peptides or small proteins that show novel biological properties in human cells. We show these pri-miRNA (miR-200a and miR-200b)-encoded peptides/proteins (miPEP-200a and miPEP-200b) to inhibit the migration of cancer cells by regulating epithelial to mesenchymal transition of these cells. These miPEPs have the potential to serve as diagnostic markers for metastasis and can also be used as therapeutic agents to many cancers (including gynecological cancers). We will also discuss how these novel peptides/proteins encoded by pri-miRNAs are evolved in nature and their potential role in cancer and other human diseases. These results may revolutionize our present understanding of the functional role of the so called junk DNA (non-coding DNA) and its noncoding RNAs in the biology of humans and animals.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jinbo Fang”
  • BylineArticles whose byline prints “Sharif Morsalin”
  • BylineArticles whose byline prints “Linda Egbosiuba”
  • BylineArticles whose byline prints “Veena N Rao”
  • BylineArticles whose byline prints “E Shyam P Reddy”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels